𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma

✍ Scribed by Ann-Lii Cheng; Yao-Chang Chen; Kun-Huei Yeh; Shuang-En Chuang; Bor-Rong Chen; Ding-Shinn Chen

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
567 KB
Volume
77
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Advancing the diagnosis and treatment of
Advancing the diagnosis and treatment of hepatocellular carcinoma
✍ J. Wallis Marsh; Sydney D. Finkelstein; Myron E. Schwartz; M. Isabel Fiel; Igor πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

We analyzed global gene expression patterns of 91 human hepatocellular carcinomas (HCCs) to define the molecular characteristics of the tumors and to test the prognostic value of the expression profiles. Unsupervised classification methods revealed two distinctive subclasses of HCC that are highly a

High dose tamoxifen plus cisplatin and e
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
✍ Chih-Hsin Yang; Ann-Lii Cheng; Kun-Huei Yeh; Chong-Jen Yu; Jing-Fang Lin; Pan-Ch πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## BACKGROUND. Tamoxifen sensitizes cancer cells to chemotherapeutic agents. High dose tamoxifen has been tested in the treatment of patients with melanoma and other cancers. The authors conducted a Phase II study of high dose tamoxifen plus cisplatin and etoposide for patients with advanced, inop

Use of tamoxifen in advanced-stage hepat
Use of tamoxifen in advanced-stage hepatocellular carcinoma : A systematic review
✍ Anna K. Nowak; Martin R. Stockler; Pierce K. H. Chow; Michael Findlay πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 126 KB

## Abstract ## BACKGROUND Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide. Survival is poor for patients with advanced‐stage HCC, and small trials of tamoxifen for patients with this disease have shown conflicting results. The authors conducted a systema

Oral capecitabine for the treatment of h
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma
✍ Yehuda Z. Patt; Manal M. Hassan; Alvaro Aguayo; Ajay K. Nooka; Richard D. Lozano πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Background: The goal of the current study was to evaluate the efficacy and toxicity of capecitabine in patients with nonresectable hepatobiliary carcinoma. ## Methods: The authors performed a retrospective analysis of all patients with hepatocellular carcinoma (hcc), cholangiocarcinoma (cca),

Mitotane associated with etoposide, doxo
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma
✍ Alfredo Berruti; Massimo Terzolo; Anna Pia; Alberto Angeli; Luigi Dogliotti πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

BACKGROUND. The use of either mitotane or chemotherapy in the treatment of advanced adrenocortical carcinoma (ACC) has led to scanty and controversial results. The recent finding that mitotane is able to reverse in vitro multidrug resistance has provided a rational basis for combining this agent wit